Ha Tay Pharmaceuticals – Hataphar has been honored among the Top 100 Most Representative Brands in Vietnam at the 2024 Golden Star of Vietnam Awards. This is the second time the company has participated in the award and winning, which reaffirms Ha Tay Pharmaceuticals’ position in the healthcare industry and the Vietnamese economy as a whole.
On December 24, 2024, at the National Convention Center in Hanoi, Ha Tay Pharmaceuticals – Hataphar proudly received the 2024 Golden Star of Vietnam Award and was recognized as one of the Top 100 Most Representative Brands in Vietnam. The Golden Star of Vietnam Award is one of the most prestigious national awards, presented to the most outstanding Vietnamese businesses, not only in the field of business but also as a symbol of will, creativity, and social responsibility; affirming that the Vietnamese brand can be compared and competed with the world.
This year’s award received applications from 293 businesses from 53 provinces and cities nationwide. After successfully passing the dossier examination round, the award council’s assessment team, consisting of economic experts, leaders of leading businesses, leaders of the Vietnam Young Business Association, and media agencies, visited Ha Tay Pharmaceuticals to directly assess the company’s operations.
Being honored with the 2024 Golden Star of Vietnam Award is a well-deserved recognition, affirming the efforts of Ha Tay Pharmaceuticals – Hataphar over 60 years of building and development: continuous innovation, creativity, and a commitment to upholding the spirit of improving product and service quality at every stage to better serve the healthcare needs of the domestic population and elevate the position of Vietnamese brands on the international stage.
The upcoming year 2025 will mark a significant milestone as Ha Tay Pharmaceuticals celebrates its 60th anniversary. Simultaneously, the flagship Hataphar High-Tech Pharmaceutical Manufacturing Plant project, in collaboration with ASKA Pharmaceutical CO., LTD (Top 20 pharmaceutical companies in Japan), is also expected to receive the Japan – GMP certificate, marking the initial achievement of the company’s determination to invest in research, development, and fostering a creative environment; applying new technologies to keep pace with global scientific advancements, aiming to export Vietnamese pharmaceuticals to the world, ensuring the highest quality products reach consumers, and being ready to participate in the global pharmaceutical supply chain.
With nearly 60 years of experience in healthcare, Ha Tay Pharmaceuticals – Hataphar is committed to promoting the values the company upholds while creating sustainable value for society.
